Medco, AssureRx Partner In Trial To Improve Psychotropic Medication Adherence Through Genetic Testing
This article was originally published in The Pink Sheet Daily
Medco does not expect results to alter reimbursement decisions, but to offer another tool to help physicians make prescribing decisions.
You may also be interested in...
Express Scripts’ caution about the cost effectiveness of some genetic testing could hint at how interested it will be in continuing the pharmacogenomic programs sponsored by former rival PBM Medco, which Express acquired in early April.
DNA Direct adds genetic testing guidance and decision-support capacity to Medco's burgeoning personalized medicine portfolio.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.